NAFLD-derived plasminogen activator inhibitor 1, vascular endothelial growth factor (VEGF) or angiopoietin may be involved in metastasis and thus cancer progression [54]. Here, VEGFA is linked to metabolic dysfunction-associated steatotic liver disease.